References
1.
Kazuya
Kondo , Kiyoshi
Yoshizawa, Masaru
Tsuyuguchi, Suguru
Kimura, Masayuki
Sumitomo, Junji Morita, Takanori
Miyoshi, Shoji
Sakiyama, Kiyoshi
Mukai, Yasumasa
Monden. Ann thorac surg 2004(4); 77:1183-8
2.
Sonia
Berrih-Aknin , Rozen
Le Panse. Myasthenia Gravis: A Comprehensive Review of Immune
Dysregulation and Etiological Mechanisms. J Autoimmun 2014(8): 52,
90-100
3.
E
Saka, M
A
Topcuoglu, B
Akkaya, A
Galati, M
Z
Onal, A
Vincent. Thymus Changes in anti-MuSK-positive and -Negative Myasthenia
Gravis. Neurolohy 2005(9):65,782-783
4. E. K. Deenick and C. S. Ma. The regulation and role of T follicular
helper cells in immunity. Immunology 2011; 134(4):361–367
5.
Kim
L
Good-Jacobson, Courtney
G
Szumilas, Lieping
Chen, Arlene
H
Sharpe, Mary
M
Tomayko, Mark
J Shlomchik. PD-1 Regulates Germinal Center B Cell Survival and the
Formation and Affinity of Long-Lived Plasma Cells. Nat Immunol. 2010
June; 11(6): 535–542
6.
Yang
Song, Lei
Zhou, Feng
Miao, Gang
Chen, Yongjun Zhu, Xue Gao, Yiqing Wang, Liewen Pang, Chongbo
Zhao, Xiaotian Sun, Zhiming Chen. Increased Frequency of Thymic T
Follicular Helper Cells in Myasthenia Gravis Patients with Thymoma. J
Thorac Dis 2016;8(3):314-322
7.
Min
Zhang, Yongan
Zhou, Jun
Guo, Hongzeng
Li, Feng
Tian Li
Gong, Xianni
Wang, Miao
Lan, Zhuyi
Li, Wei
Zhang. Experimental Neurology 2014; 254: 200 –205
8. Hakiri S, Fukui T, Mori S, Kawaguchi K, Nakamura S, Ozeki N, Kato T,
Goto M, Yatabe Y, Yokoi K.
Clinicopathologic
Features of Thymoma With the Expression of Programmed Death Ligand 1.
Ann Thorac Surg. 2019 Feb;107(2):418-424.
9.Prerna
Guleria, Nuzhat
Husain, Saumya
Shukla, Sunil
Kumar, Rajinder
Parshad, Deepali
Jain. PD-L1 Immuno-Expression Assay in Thymomas: Study of 84 Cases and
Review of Literature. Annals of Diagnostic Pathology 34 (2018) 135–141
10.
Julia
A
Brown, David
M
Dorfman, Feng-Rong
Ma, Elizabeth
L
Sullivan, Oliver
Munoz, Clive
R
Wood, Edward
A
Greenfield, Gordon
J Freeman. Blockade of Programmed death-1 Ligands on Dendritic Cells
Enhances T Cell Activation and Cytokine Production. J Immunol February
1, 2003, 170 (3) 1257-1266
11.
Mohammad
Reza
Zamani, Saeed
Aslani, Arash
Salmaninejad, Mohammad
Reza Javan, Nima Rezaei. PD-1/PD-L and Autoimmunity: A Growing
Relationship. Cellular Immunology 310 (2016) 27–41
12. Yokoi K, Kondo K, Fujimoto K. JLCS medical practice guidelines for
thymic tumors: summary of recommendations. Jpn J Clin Oncol 2017;
47:1119–22.
13.
Huayu
Yang, Xiaoxiang Zhou, Lejia Sun, Yilei Mao. Correlation Between PD-L2
Expression and Clinical Outcome in Solid Cancer Patients: A
Meta-Analysis. Front oncol.2019;9:47
14.
Kenji
Ishiwata, Naohiro
Watanabe, Miao
Guo, Kei
Tomihara, Michael
J
Brumlik, Hideo
Yagita, Drew
Pardoll, Lieping
Chen, Tahiro Shin. Costimulator B7-DC Attenuates Strong Th2 Responses
Induced by Nippostrongylus Brasiliensis. J Immunol. (2010) 184:2086–94
15.
Isabelle
Rouquette, Estelle
Taranchon-Clermont, Julia
Gilhodes, Maria-Virginia
Bluthgen, Romain
Perallon, Lara
Chalabreysse, Anne
De
Muret, Veronique
Hofman, Alexander
Marx, Marie
Parrens, Veronique
Secq, Vincent
Thomas de
Montpreville, Françoise
Galateau-Salle, Pierre
Brousset, Julie
Milia, Nicolas
Girard, Benjamin
Besse, Thierry
Jo
Molina, Julien
Mazières. Immune Biomarkers in Thymic Epithelial Tumors: Expression
Patterns, Prognostic Value and Comparison of Diagnostic Tests for PD-L1.
Biomark Res. 2019; 7:28
16.
Sukhmani
K
Padda, Jonathan
W
Riess, Erich
J
Schwartz, Lu
Tian, Holbrook
E
Kohrt, Joel
W
Neal, Robert
B
West, Heather
A Wakelee. Diffuse High Intensity PD-L1 Staining in Thymic Epithelial
Tumors. J thorac oncol 2015; 10:500-8
17.
Marcello
Tiseo, Angela
Damato, Lucia
Longo, Fausto
Barbieri, Federica
Bertolini, Alessandro
Stefani, Mario
Migaldi, Letizia
Gnetti, Roberta
Camisa, Paola
Bordi, Sebastiano
Buti, Giulio
Rossi.Analysis of a Panel of Druggable Gene Mutations and of ALK and
PD-L1 Expression in a Series of Thymic Epithelial Tumors (TETs). Lung
cancer 2017; 104:24-30
18.
Lorenzo
Maggi, Francesca
Andreetta, Carlo
Antozzi, Fulvio
Baggi, Pia
Bernasconi, Paola
Cavalcante, Ferdinando
Cornelio, Giuseppe
Muscolino, Lorenzo
Novellino, Renato
Mantegazza. Thymoma-associated Myasthenia Gravis: Outcome, Clinical and
Pathological Correlations in 197 Patients on a 20-year Experience.
Journal of Neuroimmunology 201–202 (2008) 237–244
19.
Philipp
Ströbel, Andrea
Bauer, Bernhard
Puppe, Til
Kraushaar, Axel
Krein, Klaus
Toyka, Ralf
Gold, Michael
Semik, Reinhard
Kiefer, Wilfred
Nix, Berthold
Schalke, Hans
Konrad
Müller-Hermelink, Alexander
Marx. Tumor Recurrence and Survival in Patients Treated for Thymomas
and Thymic Squamous Cell Carcinomas: A Retrospective Analysis. J. Clin.
Oncol. 22,1501-1509
20. Evoli, A., Minisci, C., Di Schino, C., Marsili, F., Punzi, C.,
Batocchi, A.P., Tonali, P.A., Doglietto, G.B., Granone, P., Trodella,
L., Cassano, A., Lauriola, L. Thymoma in patients with MG:
characteristics and longterm outcome. Neurology 2002;59, 1844–1850
21. Okumura, M., Ohta,M. ,Tateyama,H.,Nakagawa,K.,Matsumura,A.,Maeda,H.,
Tada, H., Eimoto, T., Matsuda, H., Masaoka, A.. The World Health
Organization histologic classification system reflects the oncologic
behavior of thymoma: a clinical study of 273 patients. Cancer 2002; 94,
624–632
22.
Kazuya
Kondo, Yasumasa
Monden. Thymoma and Myasthenia Gravis: A Clinical Study of 1,089
Patients From Japan. Ann Thorac Surg. 2005 Jan;79(1):219-24
23.
Jianyong
Zou, Chunhua
Su, Xueping
Lun, Weibing
Liu, Weiling Yang, Beilong
Zhong, Haoshuai
Zhu, Yiyan Lei, Honghe Luo, Zhenguang Chen. Preoperative Anxiety in
Patients With Myasthenia Gravis and Risk for Myasthenic Crisis After
Extended Transsternal Thymectomy: A CONSORT Study. Medicine (Baltimore).
2016 Mar;95(10):e2828
24.
Jianfei
Shen, Hongtao Tie, Anyi
Xu, Dan
Chen, Dehua
Ma, Bo
Zhang, Chengchu Zhu, Qingchen Wu. Inter-relationship Among Myasthenia
Gravis, WHO Histology, and Masaoka Clinical Stage and Effect on Surgical
Methods in Patients With Thymoma: A Retrospective Cohort Study. J Thorac
Dis. 2018 May;10(5):2981-2990
25.
Enrico
Ruffini, Pier
Luigi
Filosso, Claudio
Mossetti, Maria
Cristina
Bruna, Domenico
Novero, Patrizia
Lista, Caterina
Casadio, Alberto
Oliaro.Thymoma: Inter-Relationships Among World Health Organization
Histology, Masaoka Staging and Myasthenia Gravis and Their Independent
Prognostic Significance: A Single-Centre Experience. Eur J Cardiothorac
Surg 2011; 40:146-53
26.
Alexander
Marx , Hans
Konrad
Müller-Hermelink, Philipp
Ströbel. The Role of Thymomas in the Development of Myasthenia Gravis.
Ann.N.Y.acad.sci. 2003 998:223-236